Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide PK/PD in healthy men and women
NCT04921124Phase 3Completed
- Sponsor
- Norfolk and Norwich University Hospitals NHS Foundation Trust
- Start
- May 2021
- Primary completion
- Jul 2021
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Terossa in stress fracture, sponsored by Norfolk and Norwich University Hospitals NHS Foundation Trust. Primary endpoints: Area Under the Curve of Teriparatide at 24 hours and Maximum Concentration of Teriparatide at 24 hours. Started May 2021; status: completed.
02
Drugs
Terossa
03
Conditions
stress fracture
Beyond the preview
Go deeper on NCT04921124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04921124.